Literature DB >> 23348385

Clear cell papillary cystadenocarcinoma of the epididymis: a case report and immunohistochemistry of markers for renal cell carcinoma.

Tatsuru Nozawa1, Ryuichiro Konda, Taisuke Ohsawa, Makoto Yoshida, Masayo Komatsu, Takahide Iwama, Tomoaki Fujioka.   

Abstract

Neoplasms of the epididymis are uncommon, and malignant tumors are extremely rare. We report a case of clear cell papillary cystadenocarcinoma of the epididymis presenting with a long history of painless scrotal mass on the left side. Immunohistochemical markers for clear cell renal cell carcinoma (RCC) were examined to distinguish between clear cell papillary cystadenocarcinoma of the epididymis and metastatic clear cell renal cell carcinoma. The present case was positive for cytokeratin-7, PAX2, vinculin, vimentin and carbonic anhydrase IX. Expression of CD10 was focally observed. In contrast, no immunoreactivities for α-methylacyl-CoA racemase, RCC marker, glutathione S-transferase α or C-KIT were detected. The immunophenotypic profile of clear cell papillary cystadenocarcinoma of the epididymis closely resembles that of clear cell papillary RCC, although the immunohistochemical markers tested in this study are useful to make a differential diagnosis between clear cell papillary cystadenocarcinoma of the epididymis and metastatic clear cell RCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23348385     DOI: 10.14670/HH-28.321

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  2 in total

1.  Epididymal papillary cystadenocarcinoma metastasising to the testis in a patient with infertility managed with Onco-microTeSE.

Authors:  Nisha Pindoria; Yurina Miki; Andrea Tay; Ashish Chandra; Christopher Anderson; Evangelos Zacharakis; Majed Shabbir
Journal:  J Surg Case Rep       Date:  2016-11-24

Review 2.  Clinicopathological Characteristics, Treatment, and Prognosis of Rarely Primary Epididymal Adenocarcinoma: A Review and Update.

Authors:  Zi-Jun Zou; Ying-Ming Xiao; Zhi-Hong Liu; Ruo-Chen Zhang; Jia-Yu Liang; Yong-Quan Tang; Yi-Ping Lu
Journal:  Biomed Res Int       Date:  2017-12-20       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.